BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vio R, Proietti R, Rigato M, Calò LA. Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance. Pharmaceuticals (Basel) 2021;14:279. [PMID: 33808739 DOI: 10.3390/ph14030279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lenoir C, Terrier J, Gloor Y, Gosselin P, Daali Y, Combescure C, Desmeules JA, Samer CF, Reny J, Rollason V. Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. JPM 2022;12:526. [DOI: 10.3390/jpm12040526] [Reference Citation Analysis]
2 Stoica MC, Gáll Z, Gliga ML, Căldăraru CD, Székely O. Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease. Medicina (Kaunas) 2021;57:422. [PMID: 33925501 DOI: 10.3390/medicina57050422] [Reference Citation Analysis]